The estimated Net Worth of John W Palmour is at least $37 Milhão dollars as of 18 March 2022. John Palmour owns over 10,000 units of Novan Inc stock worth over $6,242 and over the last 21 years he sold NOVN stock worth over $37,025,990. In addition, he makes $0 as Independent Director at Novan Inc.
Sign up
John Palmour NOVN stock SEC Form 4 insiders trading
John has made over 35 trades of the Novan Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently he bought 10,000 units of NOVN stock worth $36,400 on 18 March 2022.
The largest trade he's ever made was buying 200,000 units of Novan Inc stock on 3 March 2020 worth over $18,000. On average, John trades about 28,511 units every 123 days since 2003. As of 18 March 2022 he still owns at least 69,356 units of Novan Inc stock.
You can see the complete history of John Palmour stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
John Palmour biography
Dr. John W. Palmour Ph.D. serves as Independent Director of the Company. Dr. Palmour has worked at Cree, Inc., a company he co-founded and for which he currently serves as Vice President and the Chief Technology Officer of the Wolfspeed Division. Dr. Palmour served on Cree’s board of directors from 1995 to 2010. He is currently on the board of directors of Goodzer, Inc., a privately held company focused on local services Internet advertising. Palmour’s significant experience and leadership in the technology field and the advancement of innovation to broad-scale product commercialization qualifies him to serve on our board of directors.
How old is John Palmour?
John Palmour is 58, he's been the Independent Director of Novan Inc since 2010. There are 4 older and 9 younger executives at Novan Inc. The oldest executive at Novan Inc is Robert Ingram, 77, who is the Independent Director.
What's John Palmour's mailing address?
John's mailing address filed with the SEC is C/O NOVAN, INC., 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703.
Insiders trading at Novan Inc
Over the last 8 years, insiders at Novan Inc have traded over $72,487 worth of Novan Inc stock and bought 1,476,993 units worth $9,839,419 . The most active insiders traders include John W Palmour, Robert J Keegan, eLife Sciences Holdings Ltd .... On average, Novan Inc executives and independent directors trade stock every 70 days with the average trade being worth of $4,566. The most recent stock trade was executed by Machelle Sanders on 27 June 2023, trading 11,553 units of NOVN stock currently worth $4,737.
What does Novan Inc do?
novan, inc. is a clinical-stage biotechnology company focused on leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. we believe that our ability to conveniently deploy nitric oxide in a solid form, on demand and in localized formulations allows us the potential to significantly improve patient outcomes in a variety of diseases.
What does Novan Inc's logo look like?
Complete history of John Palmour stock trades at Cree e Novan Inc
Novan Inc executives and stock owners
Novan Inc executives and other stock owners filed with the SEC include:
-
Paula Brown Stafford M.P.H.,
Pres, CEO & Chairwoman -
Paula Brown Stafford,
Pres, CEO & Chairwoman -
Paula Stafford,
Chairman of the Board, President, Chief Executive Officer -
John M. Gay CPA,
CFO & Corp. Sec. -
John M. Gay,
CFO & Corp. Sec. -
John Gay,
Chief Financial Officer, Vice President - Finance, Corporate Controller, Corporate Secretary -
Robert Ingram,
Independent Director -
Jenene Thomas,
Investors Relation -
Machelle Sanders,
Independent Director -
John Palmour,
Independent Director -
Robert Keegan,
Independent Director -
James Bierman,
Director -
W. Geer,
Lead Independent Director -
Stanley Hollenbach BS, J.D.,
Sr. VP of R&D -
John A. Donofrio Jr.,
Exec. VP, COO & Pres of EPI Health -
Dr. Tomoko Maeda-Chubachi M.B.A., M.D., Ph.D.,
Chief Medical Officer -
Brian M. Johnson,
Chief Commercial Officer -
Elizabeth Messersmith,
Sr. VP & Chief Devel. Officer -
Stanley Hollenbach BS,J.D.,
Sr. VP of R&D -
Cole Ikkala,
Director of Investor Relations, Communications & Bus. Devel. -
Dr. Carri Geer,
Sr. VP & CTO -
Andrew J. Novak,
VP of Accounting & Bus. Operations and Chief Accounting Officer -
Brian M. Johnson,
Chief Commercial Officer -
Life Sciences Holdings Ltd ...,
-
Sean Murphy,
Director -
Nathan Stasko,
President & CSO, Director -
G. Kelly Martin,
Chief Executive Officer -
William L Hodges,
Interim Chief Financial Office -
M. Joyce Rico,
Chief Medical Officer -
F Nealt.D.H. One, Llct.D.H....,
-
A. Donofrio John,
EVP, Chief Operating Officer -
Eugene Sun,
Director -
Jeff N Hunter,
EVP & Chief Business Officer -
Steven D Skolsky,
Director